$AHCO
AdaptHealth Corp.

2024 Q4 Form 10-Q Financial Statement

#000162828024045365 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $805.9M
YoY Change 0.23%
Cost Of Revenue $681.9M
YoY Change -1.68%
Gross Profit $124.0M
YoY Change 12.17%
Gross Profit Margin 15.39%
Selling, General & Admin $49.24M
YoY Change -21.21%
% of Gross Profit 39.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $85.20M
YoY Change -5.65%
% of Gross Profit 68.71%
Operating Expenses $60.51M
YoY Change -21.52%
Operating Profit $63.49M
YoY Change -113.77%
Interest Expense -$31.43M
YoY Change -197.29%
% of Operating Profit -49.5%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $32.03M
YoY Change -106.57%
Income Tax $8.100M
% Of Pretax Income 25.29%
Net Earnings $22.86M
YoY Change -105.03%
Net Earnings / Revenue 2.84%
Basic Earnings Per Share $0.16
Diluted Earnings Per Share $0.15
COMMON SHARES
Basic Shares Outstanding 134.6M shares 134.5M shares
Diluted Shares Outstanding 136.5M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.2M
YoY Change 78.57%
Cash & Equivalents $109.7M $100.2M
Short-Term Investments
Other Short-Term Assets $48.91M
YoY Change 16.72%
Inventory $139.8M $133.5M
Prepaid Expenses
Receivables $408.0M $401.2M
Other Receivables $0.00
Total Short-Term Assets $755.8M $683.8M
YoY Change 16.45% 16.87%
LONG-TERM ASSETS
Property, Plant & Equipment $474.9M
YoY Change -23.6%
Goodwill $2.700B $2.707B
YoY Change -0.92% -10.99%
Intangibles $105.5M $113.5M
YoY Change -18.91% -16.41%
Long-Term Investments
YoY Change
Other Assets $17.58M $17.22M
YoY Change -16.77% -23.46%
Total Long-Term Assets $3.731B $3.786B
YoY Change -3.33% -8.55%
TOTAL ASSETS
Total Short-Term Assets $755.8M $683.8M
Total Long-Term Assets $3.731B $3.786B
Total Assets $4.487B $4.470B
YoY Change -0.48% -5.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $284.6M $266.5M
YoY Change 34.56% 29.93%
Accrued Expenses $102.8M
YoY Change 11.63%
Deferred Revenue $34.94M $35.84M
YoY Change -9.4% -25.3%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $16.25M $16.25M
YoY Change -69.55% -59.38%
Total Short-Term Liabilities $567.0M $553.0M
YoY Change 5.58% 23.39%
LONG-TERM LIABILITIES
Long-Term Debt $1.965B $2.014B
YoY Change -6.19% -5.32%
Other Long-Term Liabilities $272.0M $272.8M
YoY Change -9.96% -9.83%
Total Long-Term Liabilities $2.237B $2.286B
YoY Change -6.67% -5.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $567.0M $553.0M
Total Long-Term Liabilities $2.237B $2.286B
Total Liabilities $2.909B $2.946B
YoY Change -4.38% -1.33%
SHAREHOLDERS EQUITY
Retained Earnings -$562.2M -$612.4M
YoY Change -13.86% 53.84%
Common Stock $13.00K $13.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.571B $1.516B
YoY Change
Total Liabilities & Shareholders Equity $4.487B $4.470B
YoY Change -0.48% -5.4%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $22.86M
YoY Change -105.03%
Depreciation, Depletion And Amortization $85.20M
YoY Change -5.65%
Cash From Operating Activities $144.4M
YoY Change 46.16%
INVESTING ACTIVITIES
Capital Expenditures $59.56M
YoY Change -22.75%
Acquisitions
YoY Change
Other Investing Activities $5.316M
YoY Change
Cash From Investing Activities -$54.24M
YoY Change -29.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -59.82M
YoY Change 459.04%
NET CHANGE
Cash From Operating Activities 144.4M
Cash From Investing Activities -54.24M
Cash From Financing Activities -59.82M
Net Change In Cash 30.35M
YoY Change 175.89%
FREE CASH FLOW
Cash From Operating Activities $144.4M
Capital Expenditures $59.56M
Free Cash Flow $84.85M
YoY Change 291.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001725255
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
CY2024Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
AdaptHealth Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3677704
dei Entity Address Address Line1
EntityAddressAddressLine1
220 West Germantown Pike
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
dei Entity Address City Or Town
EntityAddressCityOrTown
Plymouth Meeting
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
134554889 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100180000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77132000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
401215000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
388910000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
133490000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
113642000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
48906000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
69338000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
683791000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
649022000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
474922000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106390000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110465000 usd
CY2024Q3 ahco Finance Lease Right Of Use Asset After Accumulated Amortization Excluding Portion Within Equipment And Other Fixed Assets Net
FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationExcludingPortionWithinEquipmentAndOtherFixedAssetsNet
38769000 usd
CY2023Q4 ahco Finance Lease Right Of Use Asset After Accumulated Amortization Excluding Portion Within Equipment And Other Fixed Assets Net
FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationExcludingPortionWithinEquipmentAndOtherFixedAssetsNet
31962000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
2707282000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2724958000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
113452000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
130160000 usd
CY2024Q3 us-gaap Assets
Assets
4469936000 usd
CY2023Q4 us-gaap Assets
Assets
4508650000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
430371000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
391994000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
16250000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
53368000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2945748000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3041981000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
124060 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2935035 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2149951000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-612440000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-652600000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1625000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4356000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1516256000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1458454000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
7932000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
8215000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
805858000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2404330000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2341943000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
681866000 usd
CY2024Q3 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-3223000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1524188000 usd
CY2023Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19462
dei City Area Code
CityAreaCode
610
dei Local Phone Number
LocalPhoneNumber
424-4515
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
495101000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30276000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29270000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12307000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
9122000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
38570000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134538730 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134538730 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
124060 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
124060 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1524188000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1466669000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13078000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511866000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
742371000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1265067000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2238265000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2722540000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
63487000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-461036000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
166065000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12769000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-23656000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10956000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-25212000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-26959000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30328000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23780000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
391424000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
325400000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
228719000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6900000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.048
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30893000 usd
us-gaap Profit Loss
ProfitLoss
43377000 usd
us-gaap Profit Loss
ProfitLoss
-421205000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1155000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3217000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3187000 usd
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3500000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35842000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25758000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10654000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
553025000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
536999000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
302093000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
26098000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132634850 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132634850 shares
CY2024Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
CY2023Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#HealthCarePatientServiceMember
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2024Q3 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2023Q3 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2024Q3 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2023Q3 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
dei Trading Symbol
TradingSymbol
AHCO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
328106000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
345854000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17224000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21128000 usd
CY2024Q3 ahco Warrant Liability Current
WarrantLiabilityCurrent
2221000 usd
CY2023Q4 ahco Warrant Liability Current
WarrantLiabilityCurrent
4021000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2013644000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2094614000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80135000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85529000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
22746000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
272846000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
124060 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3935035 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25548000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
43267000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2152605000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4469936000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4508650000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
804031000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
693488000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2036532000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2022281000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49242000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45198000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154632000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142797000 usd
CY2024Q3 ahco Depreciation Expense Excluding Patient Equipment Depreciation
DepreciationExpenseExcludingPatientEquipmentDepreciation
11263000 usd
CY2023Q3 ahco Depreciation Expense Excluding Patient Equipment Depreciation
DepreciationExpenseExcludingPatientEquipmentDepreciation
14515000 usd
ahco Depreciation Expense Excluding Patient Equipment Depreciation
DepreciationExpenseExcludingPatientEquipmentDepreciation
34023000 usd
ahco Depreciation Expense Excluding Patient Equipment Depreciation
DepreciationExpenseExcludingPatientEquipmentDepreciation
45596000 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-380597000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
31429000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
32306000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
96939000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
96813000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2273000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2273000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2243000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9160000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31886000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3317000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3345000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6574000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32028000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-487499000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65308000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-452098000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8073000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-34578000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21931000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
23955000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-452921000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1096000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
22859000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-454076000 usd
us-gaap Net Income Loss
NetIncomeLoss
40160000 usd
us-gaap Net Income Loss
NetIncomeLoss
-424392000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134303000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134825000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133481000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134549000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136530000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134982000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135441000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135202000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.15
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.37
CY2024Q3 us-gaap Profit Loss
ProfitLoss
23955000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-452921000 usd
us-gaap Profit Loss
ProfitLoss
43377000 usd
us-gaap Profit Loss
ProfitLoss
-421205000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3223000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
66000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2731000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-285000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20732000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-452855000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
40646000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-421490000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1096000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1155000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3217000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19636000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-454010000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1466669000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4533000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
545000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1072000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
607000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1109000 usd
CY2024Q1 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
856000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1471029000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5218000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
261000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
20531000 usd
CY2024Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-364000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1492653000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
863000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
198000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
400000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
392000 usd
CY2024Q3 ahco Stock Issued During Period Loss Contingency Value
StockIssuedDuringPeriodLossContingencyValue
9750000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
23955000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2157758000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5916000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1883000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1021000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9224000 usd
CY2023Q1 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-2805000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2167458000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6847000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2229000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2500000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
15041000 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
2454000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2187071000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4521000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
538000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
513000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1010000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-452921000 usd
CY2023Q3 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
66000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1739772000 usd
us-gaap Profit Loss
ProfitLoss
43377000 usd
us-gaap Profit Loss
ProfitLoss
-421205000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
274797000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
290419000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13078000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511866000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10614000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
17284000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1800000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31886000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
24902000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26309000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7927000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3821000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18664000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-37033000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
367000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1394000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4247000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3926000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2273000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
ahco Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetLiability
1850000 usd
ahco Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetLiability
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
569000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
350000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12305000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10043000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21474000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
248816000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5316000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
17917000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
128000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-223403000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-266861000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
253477000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
373477000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
75000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8261000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4558000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9224000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
742000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
538000 usd
us-gaap Proceeds From Repayment Of Loans By Employee Stock Ownership Plans
ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
999000 usd
us-gaap Proceeds From Repayment Of Loans By Employee Stock Ownership Plans
ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
2031000 usd
ahco Payments For Tax Receivable Agreement
PaymentsForTaxReceivableAgreement
1432000 usd
ahco Payments For Tax Receivable Agreement
PaymentsForTaxReceivableAgreement
3202000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6429000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3500000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2500000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1794000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5253000 usd
ahco Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions
PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions
5298000 usd
ahco Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions
PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions
1500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-144973000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48668000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23048000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9871000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77132000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46272000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100180000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56143000 usd
us-gaap Interest Paid Net
InterestPaidNet
112519000 usd
us-gaap Interest Paid Net
InterestPaidNet
113083000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13015000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5727000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
46720000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
32481000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24604000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8179000 usd
ahco Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions
OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions
24604000 usd
ahco Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions
OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions
8179000 usd
ahco Assets Written Off Subject To Operating Lease Obligations
AssetsWrittenOffSubjectToOperatingLeaseObligations
3631000 usd
ahco Assets Written Off Subject To Operating Lease Obligations
AssetsWrittenOffSubjectToOperatingLeaseObligations
0 usd
ahco Liabilities Written Off Operating Lease Obligations
LiabilitiesWrittenOffOperatingLeaseObligations
3631000 usd
ahco Liabilities Written Off Operating Lease Obligations
LiabilitiesWrittenOffOperatingLeaseObligations
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
15665000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
19726000 usd
ahco Finance Lease Obligation Incurred In Exchange For Finance Lease Right Of Use Assets Additions
FinanceLeaseObligationIncurredInExchangeForFinanceLeaseRightOfUseAssetsAdditions
15665000 usd
ahco Finance Lease Obligation Incurred In Exchange For Finance Lease Right Of Use Assets Additions
FinanceLeaseObligationIncurredInExchangeForFinanceLeaseRightOfUseAssetsAdditions
19726000 usd
us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
0 usd
us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
50000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and trade accounts receivable. The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
Accounting Estimates<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition and the valuation of accounts receivable (implicit price concession), income taxes and the tax receivable agreement, equity-based compensation, warrant liability, long-lived assets, including goodwill and identifiable intangible assets, and contingencies. Actual results could differ from those estimates.</span></div>
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
805858000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
804031000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2404330000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2341943000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
805858000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
804031000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2404330000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2341943000 usd
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
29900000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
68400000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
964912000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
932082000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
489990000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
436981000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
474922000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
495101000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
85200000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
90300000 usd
us-gaap Depreciation
Depreciation
258100000 usd
us-gaap Depreciation
Depreciation
263400000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2724958000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13078000 usd
ahco Goodwill Written Off Related To Sale Of Assets
GoodwillWrittenOffRelatedToSaleOfAssets
4598000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
2707282000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511900000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511900000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6600000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
113452000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
130160000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16700000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000000.0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000.0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
21828000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
19618000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
18190000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
17936000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
17936000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
17944000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
113452000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6850000 usd
ahco Payment For Contingent Consideration Liability
PaymentForContingentConsiderationLiability
6850000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
7500000 usd
ahco Payment For Contingent Consideration Liability
PaymentForContingentConsiderationLiability
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-350000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
7850000 usd
CY2023Q3 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
400000 usd
CY2024Q3 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
0 usd
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
400000 usd
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
1400000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
266476000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
211504000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58606000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47462000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
9990000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29327000 usd
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
3935000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
57340000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
91364000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
46361000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
430371000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
391994000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20106000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
22018000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
2029894000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2147982000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
16250000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
53368000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2013644000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2094614000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
ahco Ownership Interest Number Of Votes Per Share
OwnershipInterestNumberOfVotesPerShare
1 vote
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000.0 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
631953 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9200000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3871557 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
ahco Warrants Exercised In Cashless Transaction Number Of Warrants
WarrantsExercisedInCashlessTransactionNumberOfWarrants
0 shares
ahco Warrants Exercised In Cashless Transaction Number Of Warrants
WarrantsExercisedInCashlessTransactionNumberOfWarrants
0 shares
CY2023Q4 ahco Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
4021000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1800000 usd
CY2024Q3 ahco Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
2221000 usd
CY2022Q4 ahco Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
38503000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31886000 usd
CY2023Q3 ahco Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
6617000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3409000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.90
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M24D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
245000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
735000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
23.38
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2429000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M18D
ahco Stock Issued During Period Shares Stock Options Exercised Cash Basis
StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis
207002 shares
ahco Stock Issued During Period Shares Stock Options Exercised Cash Basis
StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis
200000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
700000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
500000 usd
ahco Stock Issued During Period Shares Stock Options Exercised Cash Basis
StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis
207002 shares
ahco Stock Issued During Period Shares Stock Options Exercised Cash Basis
StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis
200000 shares
ahco Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cashless Basis
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessBasis
38014 shares
ahco Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cashless Basis
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessBasis
1341770 shares
ahco Stock Issued During Period Stock Options Exercised Cashless Basis Shares
StockIssuedDuringPeriodStockOptionsExercisedCashlessBasisShares
13509 shares
ahco Stock Issued During Period Stock Options Exercised Cashless Basis Shares
StockIssuedDuringPeriodStockOptionsExercisedCashlessBasisShares
228466 shares
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4500000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17300000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
31100000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
22859000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-454076000 usd
us-gaap Net Income Loss
NetIncomeLoss
40160000 usd
us-gaap Net Income Loss
NetIncomeLoss
-424392000 usd
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1933000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3415000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20926000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-454076000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36745000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-424392000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9160000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31886000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
20926000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-463236000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36745000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-456278000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134303000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134825000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133481000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134549000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
157000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
653000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136530000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134982000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135441000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135202000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.15
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.37
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19833000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17883000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17883000 shares
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
10791000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
11114000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
33521000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
32186000 usd
CY2024Q3 ahco Finance Lease Right Of Use Asset Reduction
FinanceLeaseRightOfUseAssetReduction
3064000 usd
CY2023Q3 ahco Finance Lease Right Of Use Asset Reduction
FinanceLeaseRightOfUseAssetReduction
1739000 usd
ahco Finance Lease Right Of Use Asset Reduction
FinanceLeaseRightOfUseAssetReduction
7857000 usd
ahco Finance Lease Right Of Use Asset Reduction
FinanceLeaseRightOfUseAssetReduction
4746000 usd
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
663000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1721000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
6392000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
5373000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
18458000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
15932000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
101000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
358000 usd
us-gaap Sublease Income
SubleaseIncome
638000 usd
us-gaap Sublease Income
SubleaseIncome
1145000 usd
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.068
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.067
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9150000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
3726000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
33517000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
14360000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
25954000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
13098000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17717000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
9431000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13603000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
2221000 usd
CY2024Q3 ahco Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
26096000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
126037000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
42836000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15626000 usd
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4431000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
110411000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
38405000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
31130000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
32045000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8261000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4558000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24604000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8179000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
15665000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
19726000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8100000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-34600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30900000 usd
ahco Increase Decrease In Income Tax Benefit
IncreaseDecreaseInIncomeTaxBenefit
1000000.0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13100000 usd
CY2023Q3 ahco Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-39900000 usd
ahco Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-39900000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511900000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
511900000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3200000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6600000 usd
ahco Tax Receivable Agreement Percentage Savings Payable
TaxReceivableAgreementPercentageSavingsPayable
0.85
CY2024Q3 ahco Liability For Payments Under Tax Receivable Agreement
LiabilityForPaymentsUnderTaxReceivableAgreement
290200000 usd
CY2023Q4 ahco Liability For Payments Under Tax Receivable Agreement
LiabilityForPaymentsUnderTaxReceivableAgreement
291600000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-045365-index-headers.html Edgar Link pending
0001628280-24-045365-index.html Edgar Link pending
0001628280-24-045365.txt Edgar Link pending
0001628280-24-045365-xbrl.zip Edgar Link pending
ahco-20240930.htm Edgar Link pending
ahco-20240930.xsd Edgar Link pending
ahco-20240930x10qxexx311.htm Edgar Link pending
ahco-20240930x10qxexx312.htm Edgar Link pending
ahco-20240930x10qxexx32.htm Edgar Link pending
ahco-20240930_cal.xml Edgar Link unprocessable
ahco-20240930_def.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ahco-20240930_lab.xml Edgar Link unprocessable
ahco-20240930_pre.xml Edgar Link unprocessable
ahco-20240930_htm.xml Edgar Link completed